XML 31 R20.htm IDEA: XBRL DOCUMENT
v3.25.1

Net Income (Loss) Per Share | 3 Months Ended
--- | ---
Mar. 31, 2025
Net earnings (loss) per share: |
Net Income (Loss) Per Share | Note 12 – Net Income (Loss) Per Share Basic net income (loss) per share is calculated by dividing net income (loss) available to common shareholders, adjusted for preferred stock discount accretion and dividends accrued on preferred stock, by the weighted-average number of common stock outstanding during the period excluding the effects of any potentially dilutive securities. Diluted net loss per share is computed similar to basic loss per share, except that the denominator is increased to include the number of additional common stock that would have been outstanding if potential shares of common stock had been issued if such additional common stock were dilutive. As the Company had a net loss from continuing operations and discontinued operations for the three months ended March 31, 2025, the following presents dilutive and anti-dilutive securities. For continuing and discontinued operations, since there was a net loss, all securities presented below were excluded from weighted average shares outstanding. Schedule of Computation of Diluted Shares Outstanding
|  | Three Months Ended March 31, 2025 |
Anti-Dilutive: |  |  |  |
Regular warrants |  |  | 25,568 |
Stock options |  |  | 6,924 |
Series A-1 preferred stock |  |  | 601 |
Series B preferred stock |  |  | 1,040 |
Restricted Stock Units |  |  | 12,501 |
Total Anti-dilutive |  |  | 46,634 |
As the Company had a net loss from continuing operations and net income from discontinued operations for the three months ended March 31, 2024, the following presents dilutive and anti-dilutive securities. For continuing operations, since there was a net loss, all securities presented below were excluded from weighted average shares outstanding. For discontinued operations, dilutive securities presented below were included in the net income per share calculation and the anti-dilutive securities were excluded in weighted average shares outstanding:
|  | Three Months Ended March 31, 2024 |
Dilutive: |  |  |  |
Prefunded warrants |  |  | 39,130 |
MTS warrants |  |  | 209 |
Total Dilutive |  |  | 39,339 |
Anti-Dilutive: |  |  |  |
Stock options |  |  | 22,081 |
Series A-1 preferred stock |  |  | 601 |
Series B preferred stock |  |  | 1,040 |
MTS warrants |  |  | 487 |
Regular warrants |  |  | 21,187 |
Restricted Stock Units |  |  | 18,750 |
SportsHub warrants |  |  | 252 |
Total Anti-dilutive |  |  | 64,398 |
The calculation of the net income (loss) per share and weighted-average shares of the Company’s common stock outstanding for the periods presented are as follows: Schedule of Loss Per Share and Weighted-average
|  | For the Three Months Ended March 31, |
|  | 2025 |  |  | 2024 |
Net loss from continuing operations |  | $ | (916,732 | ) |  | $ | (1,760,811 | )
Less: deemed dividends on warrant exchange |  |  | - |  |  |  | (44,619 | )
Net loss from continuing operations available to common stockholders |  |  | (916,732 | ) |  |  | (1,805,430 | )
Net income (loss) from discontinued operations, net of tax, available to common stockholders |  |  | (58,169 | ) |  |  | 14,111,167 |
Net income (loss) available to common stockholders |  | $ | (974,901 | ) |  | $ | 12,305,737 |
Basic weighted-average shares for continuing and discontinued operations |  |  | 531,226 |  |  |  | 259,140 |
Diluted weighted average shares for discontinued operations |  |  | 531,226 |  |  |  | 298,479 |
Basic: |  |  |  |  |  |  |  |
Net (loss) from continuing operations per share |  | $ | (1.73 | ) |  | $ | (6.97 | )
Net income (loss) from discontinued operations per share |  |  | (0.11 | ) |  |  | 54.45 |
Net income (loss) per share |  | $ | (1.84 | ) |  | $ | 47.48 |
Fully Diluted: |  |  |  |  |  |  |  |
Net (loss) from continuing operations per share |  | $ | (1.73 | ) |  | $ | (6.97 | )
Net income (loss) from discontinued operations per share |  |  | (0.11 | ) |  |  | 47.28 |
Net income (loss) per share |  | $ | (1.84 | ) |  | $ | 40.31 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration